BUILD 3: Bosentan Use in Interstitial Lung Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

616

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

February 28, 2010

Study Completion Date

July 31, 2010

Conditions
Idiopathic Pulmonary Fibrosis
Interventions
DRUG

Bosentan

Bosentan 62.5 mg tablets twice daily (b.i.d.) for 4 weeks followed by bosentan 125 mg tablets b.i.d (if body weight \> 40 kg) or bosentan 62.5 mg tablets b.i.d. (if body weight \< 40 kg)

DRUG

Placebo

Placebo matching bosentan 62.5 mg tablets and 125 mg tablets

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Actelion

INDUSTRY